This report studies the global Human Coagulation Factor VIII market status and forecast, categorizes the global Human Coagulation Factor VIII market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/global-human-coagulation-factor-viii-2018-130
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.
The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.
Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.
The global Human Coagulation Factor VIII market is valued at 7440 million US$ in 2017 and will reach 9420 million US$ by the end of 2025, growing at a CAGR of 3.0% during 2018-2025.
The major manufacturers covered in this report
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
- North America
- Europe
- China
- Japan
- India
- Southeast Asia
- Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Recombinant Factor VIII
- Plasma-derived Factor VIII
By Application, the market can be split into
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
The study objectives of this report are:
- To analyze and study the global Human Coagulation Factor VIII capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
- Focuses on the key Human Coagulation Factor VIII manufacturers, to study the capacity, production, value, market share and development plans in future.
- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Human Coagulation Factor VIII are as follows:
- History Year: 2013-2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
- Human Coagulation Factor VIII Manufacturers
- Human Coagulation Factor VIII Distributors/Traders/Wholesalers
- Human Coagulation Factor VIII Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
Available Customizations
With the given market data, We Research offers customizations according to the company’s specific needs. The following customization options are available for the report:
- Regional and country-level analysis of the Human Coagulation Factor VIII market, by end-use.
- Detailed analysis and profiles of additional market players.
Table of content
Global Human Coagulation Factor VIII Market Professional Survey Report 2018
1 Industry Overview of Human Coagulation Factor VIII
1.1 Definition and Specifications of Human Coagulation Factor VIII
1.1.1 Definition of Human Coagulation Factor VIII
1.1.2 Specifications of Human Coagulation Factor VIII
1.2 Classification of Human Coagulation Factor VIII
1.2.1 Recombinant Factor VIII
1.2.2 Plasma-derived Factor VIII
1.3 Applications of Human Coagulation Factor VIII
1.3.1 Hemophilia A
1.3.2 Spontanous / Trauma
1.3.3 Surgical
1.3.4 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII
2.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
2.4 Industry Chain Structure of Human Coagulation Factor VIII
3 Technical Data and Manufacturing Plants Analysis of Human Coagulation Factor VIII
3.1 Capacity and Commercial Production Date of Global Human Coagulation Factor VIII Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Human Coagulation Factor VIII Major Manufacturers in 2017
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@24marketreports.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports